当前 REITs 市场经历回调后估值趋于合理，对于长期配置型资金而言具备较 高的投资性价比，可把握优质项目的逢调整配置机会。建议以三季度业绩为 依据，沿两条主线布局：一是基本面韧性较强的板块，如数据中心、保租房 等；二是四季度业绩有望实现环比改善的 REITs，如受益于国庆假期及"双 十一"促销活动的奥莱项目。 【基金】2026 年公募基金投资策略：均衡配置，顺势而为 25 年公募基金规模和份额均上升，但结构有所变化，固收+和指数权益被净 申购，固收和主动权益被净赎回。全球权益走强，国内股强债弱，基金全面 收涨，主动基金跑赢被动产品，科技、周期等主题基金表现亮眼。展望 26 年，预计权益仍具有向上空间，成长占优，建议保持景气+反转均衡配置， 灵活把握短期机会，顺势而为。配置上，践行全球多元资产配置，优选各细 分策略产品。 【电力设备】风电行业 2026 年年度策略报告：风电行业维持高景气度，看 好风机及零部件、双海投资机会 风电行业保持高景气度。我们梳理 2 条选股主线：（1）风机中标价格表现优 异，风机盈利有望回暖，且后续装机量方面具备超预期潜力，海外风电需求 高增进一步打开成长空间，风机及零部件环节有望量 ...

固定收益专题报告 逻辑一：P/NAV 回归到均值附近，配置价值逐渐显现。 自去年年初以来，伴随二级市场的强劲上涨，全市场 P/NAV 估值水平已从 均值-2 倍标准差的低位，启动了一轮持续的修复行情。25 年 7 月以来随着 市场整体调整，P/NAV 震荡下行，目前已回落至历史均值+1 倍标准差以内 的合理区间，长期资金配置窗口已打开。 逻辑二：基本面仍是核心，估值修复阶段业绩好的板块反弹动能更强。 复盘 10 月 21 日以来的市场表现，涨幅领先的为数据中心（5.34%）、保租 房（3.81%）、消费（3.28%）和市政环保（3.02%）板块。这些板块在三季 度运营情况较为稳健，成为市场资金在估值修复过程中优先配置的重点。 REITs 配置窗口渐进，聚焦三季报韧性主线 核心结论 【核心结论】 当前 REITs 市场经历回调后估值趋于合理，对于长期配置型资金而言具备 较高的投资性价比，可把握优质项目的逢调整配置机会。建议以三季度业绩 为依据，沿两条主线布局：一是基本面韧性较强的板块，如数据中心、保租 房等；二是四季度业绩有望实现环比改善的 REITs，如受益于国庆假期及"双 十一"促销活动的奥莱项目。 此外， ...

Group 1 - The wind power industry maintains a high level of prosperity, with expectations for wind turbine and component sales to rebound in profitability due to rising bidding prices and increased demand for domestic and overseas installations [1][3][28] - The average bidding price for onshore wind turbines increased by 6.86% year-on-year to 1618 RMB/kW, while the average price including towers rose by 9.78% to 2096 RMB/kW, indicating a recovery in sales profitability for turbine manufacturers [1][41] - Domestic wind turbine shipments are expected to exceed expectations in 2026, with a significant increase in bidding and approval volumes for wind projects, indicating strong future demand [1][30][39] Group 2 - The domestic offshore wind projects are progressing smoothly, with significant growth potential in deep-sea wind energy, supported by favorable policies and planning in regions like Zhejiang, Shanghai, and Guangdong [2][3] - The European offshore wind market is projected to add 8.40 GW of new installations in 2026, highlighting the potential for export opportunities in multiple segments of offshore wind energy [2][3] - The report identifies two main investment themes: (1) the recovery of wind turbine profitability and the potential for increased installation demand, and (2) the synchronized growth of domestic and international offshore wind demand, suggesting investment opportunities in related sectors such as submarine cables and foundation piles [3][28][29] Group 3 - The report emphasizes the importance of focusing on wind turbine manufacturers and components, recommending companies like Goldwind Technology, Mingyang Smart Energy, and Sany Heavy Energy for investment [3][29] - The offshore wind sector is expected to see significant growth, with recommendations for companies involved in submarine cables and foundation piles, such as Dongfang Cable and Zhongtian Technology [3][29] - The overall valuation of the power equipment industry is expected to grow in 2025, with the wind power sector presenting substantial investment opportunities due to favorable market conditions and increasing demand [28][15]

Group 1: Inflation Data - November CPI year-on-year growth increased to 0.7%, the highest since March 2024[1] - Month-on-month CPI decreased by 0.1%, better than the same period last year[1] - Food CPI month-on-month growth was 0.5%, marking four consecutive months of increase[5] Group 2: Producer Price Index (PPI) - November PPI month-on-month growth was 0.1%, continuing growth for two consecutive months[2] - Year-on-year PPI decreased by 2.2%, with a slight increase in the decline compared to the previous month[2] - Prices of non-ferrous metals continued to rise, while black metal processing prices fell[2] Group 3: Economic Outlook - The political bureau meeting indicated a focus on more proactive fiscal and moderately loose monetary policies for 2026[2] - Economic stability is expected in 2026, with inflation likely to rise and nominal GDP growth accelerating[2] - Risks include declining real estate demand and increased external uncertainties[3]

Core Conclusions - The public fund market in 2025 saw an increase in both scale and share, with significant changes in structure, as fixed income and active equity funds experienced net redemptions, while fixed income+ and index equity funds were net subscribed [1][3] - Global equity markets strengthened, with domestic stocks outperforming bonds, leading to overall gains in funds, particularly in active funds outperforming passive products, with notable performance in technology and cyclical theme funds [1][2] - For 2026, it is expected that equities will continue to have upward potential, with a recommendation to maintain a balanced allocation between growth and reversal strategies, while flexibly seizing short-term opportunities [1][4] Market Development: Total Growth and Structural Changes - The total scale of public funds surpassed 35 trillion yuan, with stock funds growing by over 1 trillion yuan, indicating a robust market expansion [13] - The number of public funds increased to 13,300, with significant growth in stock and REITs funds, while money market and alternative investment funds saw a decline [13][25] - Active equity funds grew by 21%, with a notable recovery in new fund launches, particularly in technology theme funds, which saw a growth rate exceeding 50% [1][2][29] Performance Analysis: Strong Equity and Weak Bonds - The performance of various asset classes showed that equities outperformed bonds, with gold reaching new highs and equity assets experiencing a broad rally [2][9] - Active funds outperformed passive funds, with specific themes such as TMT, cyclical, and advanced manufacturing showing strong results [9][2] - Fixed income+ funds demonstrated superior performance, particularly those with high allocations to fixed income and convertible bonds [9][20] Investment Strategies: Balanced Allocation and Trend Following - The report suggests a balanced allocation strategy for equity funds, emphasizing the importance of flexibility in capturing phase-specific market opportunities [4][3] - For fixed income funds, the emergence of the fixed income+ era is highlighted, with a focus on asset and strategy characteristics based on risk preferences [5][39] - The report advocates for a global multi-asset allocation approach, emphasizing the value of overseas and commodity funds, with recommendations to follow QDII quotas and focus on mutual recognition funds and southbound ETFs [6][32]

Investment Rating - The report indicates a focus on the commercial aerospace and computing power industry chain, suggesting a positive outlook for these sectors [3]. Core Insights - The market showed significant differentiation, with technology growth leading while cyclical consumption faced pressure. The computing power hardware sector, particularly influenced by the news of NVIDIA being allowed to sell H200 chips to China, demonstrated resilience [3]. - The North Exchange market, primarily composed of specialized and innovative enterprises, has not directly benefited from the influx of funds into the computing power sector but still exhibited some anti-dip characteristics among tech-heavy stocks [3]. - The current valuation of the North Exchange 50 Index is at a low percentile compared to the past year, indicating a release of valuation pressure [3]. - Policy expectations are rising towards the end of the year, with a focus on stable progress and proactive fiscal measures, which may enhance market liquidity in the medium to long term [3]. Market Review - On December 9, the North Exchange A-share trading volume reached 139.2 billion, a decrease of 11.8 billion from the previous trading day. The North Exchange 50 Index closed at 1401.73, down 1.72%, with a PE_TTM of 66.35 times. The specialized and innovative index closed at 2343.91, down 1.48% [8][3]. - Among 286 companies on the North Exchange, 28 saw an increase, 1 remained flat, and 257 experienced a decline. The top five gainers included Dapeng Industrial (10.1%), Caneng Electric (5.5%), and Fangsheng Co. (5.2%), while the top five losers included Kangle Weishi (-7.5%) and Airong Software (-5.5%) [18][19]. Important News - The U.S. government has allowed NVIDIA to sell its H200 AI chips to China, imposing a 25% fee per chip, marking a significant policy shift [21]. - Demand for MLCCs is expected to grow at an annual rate of 30%, driven by AI applications, with major manufacturers like Murata and Samsung planning to expand production capacity [22].

晨会纪要 核心结论 分析师 【食品饮料】2026 消费行业投资展望：底部，是走出来的 消费行业呈现底部特征，基本面触底修复构成股价催化剂。政策面（24 年 9 月）领先资金面（25 年 Q3），资金面领先基本面，基本面触底修复构成催 化剂。除了基本面积极的信息开始增多，催化剂也包括：越来越多的公司开 始注重分红和回购，竞争理性背景下格局有所改善，白酒等公司开始清理报 表包袱，企业沟通治理更加透明和国际化。 【保险Ⅱ】保险行业 2026 年度策略：风起之时：财富权益大迁徙下的寿险 价值重估 以估值、弹性、股息率作为筛选维度，建议关注存量成本较低、经营稳健的 【中国太保】，股息率高且欠配明显的【中国平安】，业绩优异、股息率具备 竞争力的【中国人寿 H】，估值低、投资改善幅度大的【中国太平】，推荐权 益投资能力强、弹性大且股息率高的【新华保险】。 【医药生物】百奥赛图（2315.HK）深度报告：技术驱动研发创新，致力于 成为全球新药发源地 盈利预测与评级：预计 2025-2027 年公司营收分别为 13.87/18.09/23.06 亿 元，同比增长 41.5%/30.4%/27.4%，归母净利润 1.47/3.3 ...

Investment Rating - The report initiates coverage with a "Buy" rating for the company [5][15]. Core Insights - The company is positioned as a technology-driven biopharmaceutical firm focused on innovative drug development, aiming to become a global source of new drugs through proprietary gene editing technologies [1][21]. - The company has developed the RenMice® platform for discovering fully human therapeutic monoclonal antibodies and other antibody types, establishing a strong growth trajectory and high technical barriers [1][21]. - The "Thousand Mice, Ten Thousand Antibodies" initiative enhances development efficiency and supports the company's antibody licensing business, which is expected to contribute significantly to revenue growth [3][14]. Summary by Sections 1. Business Overview - The company operates two main business lines: preclinical products and services, and antibody molecule transfer development, leveraging its proprietary gene editing technology [21][22]. - The company has established a global sales system and aims to be a leading supplier of innovative animal models for drug development [25][30]. 2. Financial Performance - Revenue is projected to grow significantly, with estimates of CNY 13.87 billion, CNY 18.09 billion, and CNY 23.06 billion for 2025, 2026, and 2027 respectively, reflecting year-on-year growth rates of 41.5%, 30.4%, and 27.4% [4][15]. - The company is expected to achieve profitability in 2024, with a net profit forecast of CNY 1.47 billion, CNY 3.35 billion, and CNY 5.27 billion for 2025, 2026, and 2027, indicating substantial growth [4][15]. 3. Market Position and Competitive Advantage - The company differentiates itself from traditional model animal companies by integrating model platforms, antibody platforms, and efficacy validation platforms, creating a comprehensive technology platform [13][21]. - The company has a significant first-mover advantage in humanized models and has established a large inventory of humanized models, enhancing its competitive edge [13][14]. 4. Growth Drivers - The company’s antibody development business is expected to maintain significant growth as more antibody molecules enter clinical development, contributing to milestone revenues [11][14]. - The company has signed numerous transfer and licensing agreements, indicating a robust pipeline and potential for future revenue generation [14][15]. 5. Operational Highlights - The company has established three major animal centers in Nantong, Beijing, and Boston, enhancing its capacity to produce high-quality animal models for global clients [30][34]. - The company’s innovative animal models are considered essential resources for drug development, with a focus on validating drug efficacy in preclinical stages [70].

Investment Rating - The industry investment rating is "Overweight" and has been maintained from the previous rating [4]. Core Insights - The consumer sector is showing signs of bottoming out, with fundamental recovery acting as a catalyst for stock prices. Positive information regarding fundamentals is increasing, and companies are focusing more on dividends and buybacks [1][12]. - The "Redemption+" strategy is recommended as a short-term stable allocation strategy, with a focus on high-quality global assets and marginal recovery in specific sectors like beer and dairy [1][12]. - The report emphasizes the importance of new consumer groups and market segments, particularly the "Z Generation" and "New Middle Class," which are driving long-term structural growth in domestic demand [2][12]. Summary by Sections 1. Fundamental Outlook - The domestic consumer sector is entering a low-growth phase, with opportunities primarily in dividend-type investments and those showing marginal improvements [12]. - The "Z Generation" and "New Middle Class" are identified as key consumer groups with strong payment willingness and consumption characteristics [13][16]. - Retail channel transformations are leading to increased concentration of upstream brands, with new retail brands like "October Rice Field" showing significant growth potential [19][24]. 2. Investment Outlook for Key Sectors in 2026 - Baijiu - Guizhou Moutai's prices are nearing the bottom, indicating a long-term investment value. The current valuation corresponds to a 20x PE for 2025, with a dividend yield exceeding 3.7% [29][33]. - Jinhuijiu is gaining market share within the province, with a focus on product structure improvement and healthy inventory levels [35][39]. 3. Investment Outlook for Key Sectors in 2026 - Consumer Goods - The consumer goods sector has undergone significant cleaning of fundamentals, with no inventory burdens remaining for categories like dairy and beer [40]. - Companies like China Resources Beer and Mengniu Dairy are highlighted for their potential for improvement and growth in earnings [44]. 4. Investment Outlook for Key Sectors in 2026 - White Goods - Haier is noted for its organizational efficiency improvements and market adjustments, positioning it well for future growth [20][21]. 5. Investment Outlook for Key Sectors in 2026 - Technology Consumption - Companies like Anker and Ecovacs are recognized for their innovative platform development and operational resilience, indicating strong growth potential [22][23]. 6. Investment Outlook for Key Sectors in 2026 - Medical Aesthetics - Companies like Juzhi Biotechnology and Jinbo Biotechnology are highlighted for their technological leadership and platform upgrades, driving value reassessment [25][26]. 7. Investment Outlook for Key Sectors in 2026 - Overseas Quality Assets - Companies like Westair and Kingworld are gaining attention from domestic funds due to their strong competitive positions and growth potential in overseas markets [27][28].

行业周报 | 北交所 科技主线引领结构性修复，政策与资金共振强化配置价值 证券研究报告 2025 年 12 月 09 日 北交所市场周报——251201-251205 核心结论 北交所市场复盘：当周北交所全部 A 股日均成交额达 138.8 亿元，环比上涨 4.2%。当周北证 50 收涨 1.49%，当周日均换手率达 1.8%。当周涨幅前五 大个股分别为：豪声电子（13.9%）、优机股份（13.6%）、星图测控（13.3%）、 三协电机（13.2%）、创远信科（11.2%）；跌幅前五大个股分别为：大鹏工业 （-15.0%）、昆工科技（-13.8%）、恒拓开源（-10.6%）、迪尔化工（-9.5%）、 美登科技（-8.8%）。 重点新闻及政策：1）Palantir 携手英伟达开发软件平台，以加快 AI 数据中 心建设：Palantir、英伟达和美国公用事业公司 CenterPoint Energy 宣布， 三方正共同开发一款新的软件平台，以加速新一代人工智能（AI）数据中心 的建设；该软件系统被命名为"连锁反应"（Chain Reaction），将使用 AI 工具来协助客户；2）两部门：支持具备资质和条件的企业 ...